Empyrean Capital Partners, LP Compass Pathways PLC Transaction History
Empyrean Capital Partners, LP
- $2.57 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding CMPS
# of Institutions
173Shares Held
53.2MCall Options Held
1.86MPut Options Held
520K-
Deep Track Capital, LP Greenwich, CT8.83MShares$75.4 Million2.68% of portfolio
-
Rtw Investments, LP New York, NY8.22MShares$70.2 Million1.08% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.18MShares$35.7 Million1.56% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.36MShares$28.7 Million6.08% of portfolio
-
Gmt Capital Corp Atlanta, GA1.78MShares$15.2 Million0.64% of portfolio
About COMPASS Pathways plc
- Ticker CMPS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 42,522,400
- Market Cap $363M
- Description
- COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...